Literature DB >> 9143197

Remifentanil: an esterase-metabolized opioid.

T D Egan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9143197      PMCID： PMC1304121     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  4 in total

1.  Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.

Authors:  T D Egan; C F Minto; D J Hermann; J Barr; K T Muir; S L Shafer
Journal:  Anesthesiology       Date:  1996-04       Impact factor: 7.892

2.  Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery.

Authors:  C L Westmoreland; J F Hoke; P S Sebel; C C Hug; K T Muir
Journal:  Anesthesiology       Date:  1993-11       Impact factor: 7.892

3.  The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.

Authors:  T D Egan; H J Lemmens; P Fiset; D J Hermann; K T Muir; D R Stanski; S L Shafer
Journal:  Anesthesiology       Date:  1993-11       Impact factor: 7.892

4.  Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B).

Authors:  P S Glass; D Hardman; Y Kamiyama; T J Quill; G Marton; K H Donn; C M Grosse; D Hermann
Journal:  Anesth Analg       Date:  1993-11       Impact factor: 5.108
  4 in total
  1 in total

1.  Median effective concentration of remifentanil for the inhibition of laryngoscope-induced cardiovascular responses.

Authors:  Zhenhai Liu; Fei Wang; Weizhi Wang; Yanhua Luo
Journal:  Exp Ther Med       Date:  2016-04-18       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.